Jonathan Rubin

SUPN

Jonathan Rubin serves as SVP, Chief Medical Officer at Supernus Pharmaceuticals, Inc. (SUPN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$104.6K

Net Position

Net Seller

$104.6K

Companies Traded

SUPN

Active Period

Feb 2025 – Sep 2025

3 total trades

Most Recent

Sell SUPN

Sep 25, 2025 · $38.8K

Jonathan Rubin's Insider Trading at Supernus Pharmaceuticals, Inc. (SUPN)

Buys

0 · $0.00

Sells

3 · $104.6K

Total Shares Bought

Total Shares Sold

2,658

SUPN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Sep 25, 2025	Sell	840	$46.21	$38.8K
Mar 5, 2025	Sell	891	$33.05	$29.4K
Feb 21, 2025	Sell	927	$39.15	$36.3K

Related Insiders

Padmanabh P. Bhatt

Sr. VP of IP, CSO

SUPNSell · Mar 18, 2026

Frederick M. Hudson

Director

SUPNSell · Mar 16, 2026

Jack A. Khattar

President, CEO

SUPNSell · Mar 16, 2026

William Todd Horich

officer: SVP, Commercial Operations

SUPNSell · Mar 10, 2026

Frank Mottola

SVP, Quality, GMP, Ops, IT

SUPNSell · Mar 10, 2026

GEMAYEL GEORGES

director

SUPNSell · Mar 9, 2026

Bethany Sensenig

Director

SUPNSell · Feb 19, 2026

NEWHALL CHARLES W III

Director

SUPNSell · Oct 9, 2025

Explore More Insider Trading Data

SUPN Insider Trading Activity

View all insider trades at Supernus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity